Envetec
Envetec is an Irish clean-technology company that sells the GENERATIONS non-thermal, on-site biohazardous waste treatment system to healthcare, pharmaceutical, medical device, food and beverage, and veterinary facilities, enabling recycling of treated plastics into manufacturing feedstock.
- Company typePrivate
- Founded2021
- HeadquartersBirdhill, Ireland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Envetec does
Envetec Sustainable Technologies is an Irish clean-technology company founded in 2021 and headquartered in County Tipperary, Ireland. It has developed GENERATIONS, an on-site, non-thermal biohazardous waste treatment system that uses mechanical shredding combined with a proprietary organic biodegradable disinfectant (Vigor-Ox, a peracetic-acid and hydrogen-peroxide formula validated at 1–3% concentration and US EPA approved) to disinfect regulated medical and laboratory waste. The system achieves 6-log10 pathogen reduction (STAATT IV) — 100× more efficient than the standard STAATT III baseline — and uniquely preserves polymer integrity so that treated plastics can be recycled into manufacturing feedstock rather than landfilled or incinerated. An in-built validation chamber verifies treatment efficacy live during operation without process downtime.
The company sells GENERATIONS hardware under multi-year enterprise contracts to life-sciences customers in five verticals: healthcare, pharmaceutical and biopharma, medical device, food and beverage, and veterinary. Pricing is custom-quoted based on facility size and waste volume, with no publicly disclosed price list. Revenue also includes ongoing technical support, validation, and regulatory-compliance services. Distribution is direct enterprise field sales only, with no channel partners. GENERATIONS Connect, launched with Siemens in February 2026, adds a digital monitoring and connectivity layer to the installed base.
Named enterprise customers include Northwell Health (the largest health system in New York State), BD (Becton, Dickinson and Company, with whom Envetec completed a closed-loop recycling feasibility study in January 2026 for polystyrene Petri dishes), and Dairygold (an Irish agricultural cooperative). Regulatory approvals span the US EPA, New York State Department of Health, Massachusetts, and the UK Environment Agency, supplemented by ISO 14064-1 greenhouse gas quantification and My Green Lab ACT labels in Europe, the UK, and the US. The company is privately held, has raised approximately $10.7M in equity funding (May 2022, investors undisclosed), and employs 11–50 people.
Envetec firmographics
Firmographics- Name
- Envetec
- Legal name
- Envetec Sustainable Technologies
- Website
- https://envetec.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Envetec is an Irish clean-technology company that sells the GENERATIONS non-thermal, on-site biohazardous waste treatment system to healthcare, pharmaceutical, medical device, food and beverage, and veterinary facilities, enabling recycling of treated plastics into manufacturing feedstock.
- Ownership category
- akta.pro rank
Envetec industry classification
Industry- Product category
- Medical Waste Treatment Equipment
- NAICS
- Ventilation, Heating, Air-Conditioning, and Commercial Refrigeration Equipment Manufacturing (33341), Urethane and Other Foam Product (except Polystyrene) Manufacturing (32615)
- akta.pro primary industry
- Chemical Waste Incineration & Thermal Treatment (BPALAHAE)
- akta.pro secondary industry
- End-of-Life Vehicle (ELV) Dismantling & Depollution (Fluids, Batteries, Airbags) (EUAIAJAC)
Keywords
Where Envetec is headquartered
LocationHeadquarters
- HQ city
- Birdhill
- HQ country
- Ireland
- HQ region
- Europe
Offices1 record
Markets served
Envetec business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- GENERATIONS System Sales: Sale and installation of GENERATIONS equipment to life sciences facilities. Equipment pricing based on facility size and waste volume requirements. Includes preliminary testing of customer waste streams for suitability verification.
- Technical Support Services: Ongoing technical support and product-related customer feedback services. Includes validation support and regulatory compliance assistance for different jurisdictions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise equipment sale - custom pricing based on facility requirements |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Envetec product offering
Product offeringCore offering
Envetec designs, manufactures, and sells the GENERATIONS system, an on-site non-thermal clean-technology platform that mechanically shreds and chemically disinfects biohazardous waste (regulated medical waste, laboratory plastics, sharps) using its proprietary Vigor-Ox disinfectant. The treated output is converted into recyclable polymer flakes that can be reintroduced into manufacturing supply chains, eliminating the carbon-intensive transport and thermal treatment steps traditionally used by life sciences organizations.
Product overview
Envetec offers a single unified product called GENERATIONS, an on-site non-thermal clean technology system for biohazardous waste treatment. The product converts biohazardous waste into disinfected, recyclable polymer flakes suitable for reintroduction into manufacturing supply chains. An add-on module called GENERATIONS Connect provides monitoring and data connectivity. The system serves life science industries including healthcare, pharmaceutical, medical device, food and beverage, and veterinary sectors.
Differentiator
Problem solved
Functional benefit
Brands
- GENERATIONS: On-site, non-thermal clean technology that treats biohazardous waste and enables plastic recycling. The technology uses a proprietary organic biodegradable disinfectant (Vigor-Ox) and mechanical shredding to achieve STAATT IV level decontamination while preserving polymer properties for recycling.
Products and services
- GENERATIONS
- GENERATIONS Connect
Quantifiable outcome
- 90% reduction in biohazard waste disposal related emissions on average
- +5 more outcomes
Companies that use Envetec
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles4 records
Envetec technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Envetec partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- SiemenscorePartnership with Siemens for GENERATIONS Connect platform, integrating digital connectivity and operational monitoring capabilities into the GENERATIONS system.
- BD (Becton, Dickinson and Company)coreJoint feasibility study demonstrating closed-loop recycling solution for laboratory plastics in healthcare. Successfully processed BD BBL prepared plated media through Envetec's GENERATIONS technology, converting plastics into polymer flakes extruded into pellets and molded into new Petri dish prototypes. Both companies plan to expand the pilot and develop circular economy pathways for other high-volume healthcare consumables.
- My Green LabminorMy Green Lab provided independent ACT label certification for GENERATIONS technology in Europe, UK, and US markets, acknowledging innovation in biohazardous waste treatment.
- Carbon ActionminorIndependent London-based carbon consultancy firm that performed eight separate evaluations validating GENERATIONS carbon reduction capabilities across sites in US, UK, and Ireland.
- Healthcare Plastics Recycling Council (HPRC)minorIndustry consortium where Envetec participates in cross-value-chain collaboration to overcome systemic barriers in healthcare plastics recycling. HPRC Spring 2026 Full Council Meeting featured Envetec/BD feasibility study.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Envetec competitors and assessment
Company assessmentBroad incumbents
- Stericycle: Largest dedicated regulated medical waste management company in North America, offering collection, transport, and treatment (autoclave and incineration) services. Overlaps with Envetec's healthcare and life sciences customer base while representing the dominant incumbent whose infrastructure Envetec is positioning to displace.
- Clean Harbors: North American provider of hazardous and industrial waste management, including regulated medical waste services for healthcare and life sciences. Comparable in serving the same end markets and addressing regulated chemical/biohazardous waste streams, though with a portfolio approach rather than a single on-site solution.
- Bioquell (Ecolab): Bio-decontamination technology provider (now part of Ecolab) using hydrogen peroxide vapor for life sciences, healthcare, and pharmaceutical facilities. Comparable in offering non-thermal, chemistry-based disinfection systems to the same regulated life sciences customers, though focused on room/equipment decontamination rather than waste treatment.
- Veolia Environmental Services: Global environmental services group with a healthcare waste treatment division serving hospitals and life sciences customers across Europe and beyond. Comparable as a large-scale provider of medical waste processing with broader waste management capabilities that Envetec competes against for sustainability-focused enterprise customers.
Regional players
- MedPro Disposal: US medical waste disposal provider serving hospitals, clinics, and labs with regulated waste collection and treatment. Comparable in addressing healthcare biohazardous waste with a service-led model, though primarily US-focused and reliant on traditional disposal methods rather than on-site non-thermal treatment.
- Sharps Compliance: US-focused provider of medical, pharmaceutical, and hazardous waste management services to small and mid-quantity generators including hospitals and labs. Comparable in targeting healthcare biohazardous waste with mail-back and pickup solutions, with a primarily US geographic footprint similar to Envetec's largest disclosed market.
Emerging players
- TOMI Environmental Solutions (SteraMist): Provider of proprietary non-thermal disinfection and decontamination technology (SteraMist) for life sciences, healthcare, and public spaces. Comparable as an emerging technology company offering an alternative to thermal sterilization methods, intersecting with Envetec's non-thermal disinfection value proposition.
Direct peers
- Daniels Health: Provider of medical and sharps waste management solutions, including reusable containment and on-site treatment programs for hospitals and labs. Directly comparable to Envetec in targeting healthcare biohazardous waste with sustainability-oriented alternatives to incineration and off-site disposal.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Envetec social profiles
Digital presenceEnvetec compliance and trust
Trust signalCompliance5 records
Envetec financial estimates
Financial estimateRevenue estimate
Valuation estimate
Envetec leadership team
Management profileNumber of profiles
Profiles4 records
Envetec funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Envetec M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Envetec
What does Envetec do?
Envetec designs, manufactures, and sells the GENERATIONS system, an on-site non-thermal clean-technology platform that mechanically shreds and chemically disinfects biohazardous waste (regulated medical waste, laboratory plastics, sharps) using its proprietary Vigor-Ox disinfectant. The treated output is converted into recyclable polymer flakes that can be reintroduced into manufacturing supply chains, eliminating the carbon-intensive transport and thermal treatment steps traditionally used by life sciences organizations.
Is Envetec a public or private company?
Envetec is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Envetec founded?
Envetec was founded in 2021. It employs 11 to 50 people.
Where is Envetec based?
Envetec is headquartered in Birdhill, Ireland, in the Europe region.
How does Envetec make money?
Two revenue lines are on record. GENERATIONS System Sales are the primary driver. The others are technical Support Services.
Who are Envetec's main competitors?
Broad incumbents on record are Stericycle, Clean Harbors, Bioquell (Ecolab) and Veolia Environmental Services. Regional players are MedPro Disposal and Sharps Compliance. TOMI Environmental Solutions (SteraMist) is listed as an emerging player. Daniels Health is listed as a direct peer.
Does Envetec have an API?
No public API is recorded for Envetec.
What industry is Envetec in?
Envetec's product category is Medical Waste Treatment Equipment. Its primary akta.pro industry code is BPALAHAE, Chemical Waste Incineration & Thermal Treatment, with a secondary code of EUAIAJAC, End-of-Life Vehicle (ELV) Dismantling & Depollution (Fluids, Batteries, Airbags). Its NAICS code is 33341.